SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein

Masaki Kamio1, Takafumi Yoshida, Hisanobu Ogata

  • 1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Oncogene
|March 17, 2004
PubMed

Insights

Interferon-gamma triggers the degradation of Human Papilloma Virus (HPV) E7 protein via SOCS1, inhibiting HPV-driven cancer cell proliferation. This discovery highlights SOCS1 as a potential therapeutic target for HPV-related tumors.

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Human Papilloma Viruses (HPVs) are DNA viruses linked to cervical cancer.
  • Interferon-gamma (IFNγ) is known to inhibit HPV-infected cell proliferation by suppressing HPV E7 expression.

Purpose of the Study:

  • To investigate the mechanism by which IFNγ suppresses HPV-infected cells.
  • To explore the role of Suppressor of Cytokine Signaling-1 (SOCS1) in regulating HPV E7 protein levels and function.

Main Methods:

  • Investigated IFNγ-induced degradation of HPV E7 protein.
  • Examined the interaction between SOCS1 and HPV E7.
  • Assessed the effect of SOCS1 on Rb protein levels and cell proliferation in HPV-infected cells.
  • Utilized SOCS1-deficient and wild-type fibroblasts for functional assays.

Main Results:

  • IFNγ induces proteasome-dependent degradation of HPV E7.
  • SOCS1 interacts with HPV E7, promoting its ubiquitination and degradation in a SOCS-box-dependent manner.
  • SOCS1 overexpression increases Rb levels and suppresses proliferation of HPV-infected cervical cancer cells.
  • E7 induces anchorage-independent growth in SOCS1-deficient cells, but not in wild-type cells.

Conclusions:

  • SOCS1 plays a critical role in regulating HPV E7 protein levels and its transforming potential.
  • SOCS1 acts as a tumor suppressor in the context of HPV infection.
  • SOCS1 represents a potential therapeutic target for HPV-mediated tumors.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.